AS-IV has the potential to impede the progression of renal fibrosis by mitigating the TGF-β1/Smad and TLR4/NF-κB signaling pathways, thereby preventing fibrosis [22, 65, 66]. Here, NFKB1 is linked to renal fibrosis.